Contrafect Announces Publication of Exebacase Phase 2 Study Results in the Journal of Clinical Investigation Phase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the treatment of life-threatening MRSA bacteremia Exebacase Phase...